Publications

Journal Article Ppublish 2 citations
Electronic publication date
March 10, 2022

View on Pubmed.gov 35261625 | View on doi.org 10.3892/etm.202...

Cofilin-1 as a potential biomarker for infection.

Search for publications in this journal Exp Ther Med - 23(4):253

  • Yiping Xie

    Search for this expert
    1
  • Zhiqin Zhang

    Search for this expert
    2
  • Min Zhang

    Search for this expert
    1
  • Hui Cao

    Search for this expert
    3

Abstract

Tuberculosis (TB) induced by (), is one of the deadliest human infections worldwide. Our previous studies demonstrated cofilin-1 (CFL1) expression was significantly increased in exosomes from ()-infected macrophages. The expression of CFL1 protein in infected hosts was investigated in the present study to predict whether CFL1 could have potential as a biomarker for infection. In the present study, the mRNA and protein expression levels of CFL1 in -infected macrophages and supernatants were analyzed via reverse transcription-quantitative PCR and western blotting. Furthermore, CFL1 expression in macrophages was knocked down , and then CFL1 expression levels in -infected macrophages and supernatant were detected via western blotting and ELISA. In addition, CFL1 was detected in the peripheral blood mononuclear cells and plasma of patients with TB using western blotting and ELISA. The specificity and sensitivity of CFL1 as a biomarker and the association between TB infection and normal individuals were compared and analyzed using GraphPad Prism 5. CFL1 protein expression levels were significantly increased in -infected macrophages and supernatant. Meanwhile, CFL1 was upregulated in patients with TB. Bioinformatics statistics indicated the high specificity and sensitivity of CFL1 in patients with TB. Thus, these results suggest that CFL1 may act as a potential biomarker of TB infection.

References

Int J Tuberc Lung Dis. 2001 Mar;5(3):213-5

Mol Biol Cell. 2005 Feb;16(2):649-64

Front Microbiol. 2022 Jan 06;12:800807

Sci Rep. 2017 Jan 19;7:40953

Conflict of interest statement

The authors declare that they have no competing interests.

MeSH

Specialties

Copyright

Copyright: © Xie et al.